Full text is available at the source.
Abstract
Bifidobacterium breve i1088 lysate may influence glucagon-like peptide-1 (GLP-1) secretion.
- The secretion of GLP-1 is associated with the pathogenesis of type 2 diabetes mellitus (T2DM).
- Postbiotics are emerging as potential therapies for metabolic modulation.
- Identifying the key active molecules in Bifidobacterium breve i1088 lysate is essential for understanding its effects.
Simplified